Where does Alexander Vos work?

Alexander Vos is Venture Partner at BioGeneration Ventures.

What check size does Alexander Vos write?

Alexander Vos typically writes checks of $100K – $1M.

Where did Alexander Vos go to school?

Alexander Vos studied at Stanford University Graduate School of Business (Director’s Consortium - Public Company Directors Program); GLH – Centrum für Strategie und Höhere Führung (Privatissimum für Aufsichtsräte und Beiräte); Stanford University Graduate School of Business (Master of Business Administration (M.B.A.), Business Administration).

Alexander Vos

Investor

Venture Partner at BioGeneration Ventures

Netherlands

Writes $100K – $1M checks · typically $500K

Find your path to Alexander

1,417 people in our graph share verified history with Alexander — schools, employers, funds. One of them is your warm intro.

Mike VolpiunlockedAlexander: together at Stanford University Graduate School of Business (1992–1994)

Alexander: together at McKinsey & Company

×10Alexander: together at Stanford University Graduate School of Business

About

Alexander Vos is Chairman of the Board at Scenic Biotech and Managing Director of Biotech Mountains. He has held executive and board positions in biopharmaceuticals, with experience in orphan and rare diseases, cell and gene therapy, strategy, investor relations, and mergers and acquisitions. He holds an MBA from Stanford University Graduate School of Business.

Experience

Scenic BiotechChairman of the Boardcurrent2025 — presentAmsterdam, North Holland, Netherlands
RoslinCTMember Board of Directorscurrent2024 — presentEdinburgh (Scotland) and Boston area (USA)
InnoCore PharmaceuticalsChairman of the Boardcurrent2024 — presentGroningen, Netherlands
Teknova Inc.Member Board Of Directorscurrent2021 — presentHollister, California, United States
BGV (BioGeneration Ventures)Venture Partnercurrent2019 — presentNaarden
Biotech Mountains BVManaging Directorcurrent2018 — presentMaastricht
CiMaas BVMember of the Supervisory Board2018 — 2024Maastricht
VectorY TherapeuticsChief Executive Officer2021 — 2023Amsterdam
VectorY TherapeuticsSenior Advisor - General management, corporate strategy2020 — 2021Amsterdam
SymeresChairman Of The Board2018 — 2021Nijmegen, Groningen
VarmXChief Executive Officer2018 — 2021Leiden, The Netherlands
Alliance for Regenerative MedicineMember Board of Directors2015 — 2018Washington D.C.
PharmaCell B.V.Chief Executive Officer (CEO)2009 — 2017The Netherlands
Medisse BVMember of the Supervisory Board2010 — 2015Leusden, The Netherlands
Alliance for Advanced Therapies, EuropeExecutive Committee2012 — 2015Brussels
Biomedical MaterialsMember of the Supervisory Board2011 — 2014The Netherlands
PAION AGChief Executive Officer (Deputy) and Chief Operating Officer2004 — 2009Germany
MediService AGChief Executive Officer2000 — 2004Switzerland
Genzyme Europe B.V.Director Business Development1994 — 1999
McKinsey & CompanyEngagement Manager1989 — 1994

Skills & more

Cell Therapy4Biotechnology23Lifesciences7Clinical Trials7Licensing3Corporate FinanceInvestor RelationsMarketing1Sales Management1Business Development10Business Acquisition1Board of Director experience1

+9 more

Operations ManagementLife SciencesBoard of DirectorsBiopharmaceuticalsOncologyStart-upsStrategic PlanningStrategyPharmaceutical Industry

Languages Dutch · English · French · German

From Alexander's professional profile.

Colleagues at BioGeneration Ventures

Alisa Meshulam

Financial Controller at Gemini Israel Ventures

Andree Blaukat

Senior Advisor at BioGeneration Ventures

Arnon Kater

Senior Advisor at BioGeneration Ventures

Arnoud Dijkstra

Venture Partner at BioGeneration Ventures

Claire van Viersen

Executive Assistant at BioGeneration Ventures

Cyril Lesser

Vice President Finance | Funds at BioGeneration Ventures

Daniela Couto

General Partner at BioGeneration Ventures

Diede Brunen

Principal at BioGeneration Ventures

Network5

Arnoud Dijkstra

Venture Partner at BioGeneration Ventures

Daniela Couto

General Partner at BioGeneration Ventures

Diede Brunen

Principal at BioGeneration Ventures

Edward van Wezel

Managing Partner at BioGeneration Ventures

Joost Holthuis

Venture Partner at BioGeneration Ventures

Investors connected to Alexander in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alexander Vos?: Alexander Vos is Chairman of the Board at Scenic Biotech and Managing Director of Biotech Mountains. He has held executive and board positions in biopharmaceuticals, with experience in orphan and rare diseases, cell and gene therapy, strategy, investor relations, and mergers and acquisitions. He holds an MBA from Stanford University Graduate School of Business.
Where does Alexander Vos work?: Alexander Vos is Venture Partner at BioGeneration Ventures.
What check size does Alexander Vos write?: Alexander Vos typically writes checks of $100K – $1M.
Where did Alexander Vos go to school?: Alexander Vos studied at Stanford University Graduate School of Business (Director’s Consortium - Public Company Directors Program); GLH – Centrum für Strategie und Höhere Führung (Privatissimum für Aufsichtsräte und Beiräte); Stanford University Graduate School of Business (Master of Business Administration (M.B.A.), Business Administration).